电刺激设备市场－全球产业规模、份额、趋势、机会及预测（按产品、适应症、最终用户、地区和竞争格局划分，2021-2031年）

全球伤口电刺激设备市场预计将从 2025 年的 2.1064 亿美元成长到 2031 年的 3.1276 亿美元，复合年增长率为 6.81%。

这些专用医疗设备透过向伤口部位输送可控电流来促进慢性及急性伤口的癒合。该市场的成长主要受全球糖尿病、静脉功能不全等文明病的日益增加所驱动。这些疾病往往会导致复杂且难以癒合的溃疡，而随着全球人口老化，人们迫切需要有效、非侵入性的治疗方法，以减少住院时间和长期医疗成本。

儘管有这些成长要素，但市场仍面临许多障碍，包括先进刺激设备的高成本和不一致的报销制度，这限制了经济敏感地区的患者获得治疗的机会。这些经济障碍往往会阻碍医疗服务提供者采用临床有效的治疗方法。慢性疾病带来的巨大负担凸显了先进创伤护理解决方案的紧迫性。例如，国际糖尿病联盟报告称，到2025年，“全球约有5.89亿成年人将患有糖尿病，这是导致需要先进伤口管理的慢性足部溃疡的主要原因”，这表明需要此类干预措施的患者群体规模庞大。

市场驱动因素

慢性难癒合伤口的增加是全球伤口电刺激设备市场的主要驱动力。糖尿病和静脉功能不全等文明病相关疾病的增加，导致复杂溃疡病例激增，这些溃疡需要透过标准疗法无法完全解决的组织修復问题。已开发国家的情况尤其突出，人口结构的变化导致难癒合病变高风险患者数量增加。为了更清楚地阐述这项需求，Bombadis 在 2025 年 5 月发布的《糖尿病足溃疡的全球现况与挑战》报告中指出，美国每年约有 160 万人患有糖尿病足溃疡。这为旨在促进伤口癒合的刺激技术提供了巨大的市场机会。

同时，对经济高效的创伤护理策略（旨在最大限度减少住院时间）的需求推动了电刺激设备的普及。医疗系统正优先采用适合居家照护和门诊环境的治疗方法，以减轻与慢性伤口相关的长期住院和再入院所带来的沉重经济负担。这种经济压力促使携带式和穿戴式装置被广泛采用，这些设备在降低整体成本的同时，也能维持临床疗效。根据 Fierce Biotech 2025 年 12 月发表的一篇报导《创伤护理的转折点》的文章，美国每年在慢性伤口护理上的支出约为 250 亿美元，这迫使支付方探索高效的先进治疗方法。史密斯医疗 (Smith & Nephew) 2025 年的报告也反映了这一市场趋势，该报告显示，其先进伤口管理部门在 2024 年第四季度的基础收入增长了 12.2%。

市场挑战

全球市场扩张的主要障碍在于先进刺激设备的高昂实施成本和不一致的保险报销政策。在对成本高度敏感的地区，由于保险覆盖范围分散且难以预测，医疗机构往往不愿投资此类专业设备。当理赔被拒或报销比例不足时，经济压力迫使医院和诊所优先考虑传统的、成本较低的创伤护理耗材，即便电刺激设备能够带来更佳的癒合效果。这种经济限制抑制了技术的普及，有效限制了收入潜力，并阻碍了广泛的商业性应用。

国际糖尿病联盟强调了这些限制性财政政策所面临的严峻经济压力，指出「预计到2024年，糖尿病将占全球卫生支出的1.15万亿美元，这将造成巨大的财政负担，迫使医疗系统实施严格的成本控制措施。」如此沉重的成本负担迫使公立和私立医疗机构密切审查支出，导致高成本的辅助性治疗常常被排除在标准医保范围之外。因此，製造商在将这些医疗设备确立为标准治疗方案方面面临持续的挑战，因为市场「即时重视短期预算节约而非长期治疗投资」。

市场趋势

市场正经历着向个人化封闭回路型治疗系统的转变，这种系统能够根据即时回馈自主调节刺激参数。与提供固定电流的传统设备不同，这些生物电子平台利用人工智慧分析癒合阶段并适当调整电输出。这种能力透过根据组织的特定需求量身定制治疗方案，提高了治疗效率。作为支持这项创新的案例研究，《科学日报》2025年9月发表的一篇报导《人工智慧驱动的智慧绷带将创伤治疗提高25%》报道称，闭合迴路设备a-Heal在临床前模型中将伤口癒合速度提高了约25%，优于标准治疗。

此外，配备智慧感测器的绷带的出现，满足了对伤口微环境进行持续、非侵入性监测的需求。这些先进的绷带内建电化学感测器，能够检测pH值和温度等生物标记物，作为感染的早期指标。透过提供客观数据，这些系统使临床医生能够主动干预。例如，2025年7月发表在《药物发现新闻》（Drug Discovery News）上的一篇题为「新型智慧绷带即时检测慢性伤口中的生物标记」的文章，就体现了这项技术的诊断潜力。这篇报导，在一项人体研究中，基于感测器数据分析，机器学习演算法能够以高达94%的准确率预测创伤治疗时间。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球伤口电刺激设备市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（有电极片的设备、不含电极片的设备）
  • 依适应症（III期及IV期压疮、静脉淤血性溃疡、动脉溃疡、糖尿病溃疡、其他）
  • 依最终用户（医院、专科诊所等）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美伤口电刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲伤口电刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区伤口电刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲伤口电刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲伤口电刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球伤口电刺激设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Accel-Heal Technologies Limited
• Vomaris Innovations, Inc.
• WoundEL Health Care
• Diapulse Corporation
• Sky Medical Technology Ltd.
• Cardinal Health, Inc.
• Talley Group Limited
• Convatec Limited
• DeRoyal Industries, Inc.
• Devon Medical, Inc

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Wound Electrical Stimulation Devices Market is projected to expand from USD 210.64 Million in 2025 to USD 312.76 Million by 2031, reflecting a CAGR of 6.81%. These specialized medical instruments function by delivering regulated electrical currents to injury sites, thereby expediting the closure of both chronic and acute wounds. The market is largely underpinned by the rising global incidence of lifestyle-related conditions, such as diabetes and venous insufficiency, which frequently result in complex, hard-to-heal ulcers. Furthermore, an aging global demographic creates a strong necessity for effective, non-invasive therapies capable of shortening hospital stays and reducing long-term healthcare expenditures.

Despite these growth drivers, the market faces significant hurdles due to the high cost of advanced stimulation units and inconsistent reimbursement frameworks, which restrict accessibility in economically sensitive regions. Such financial barriers often discourage healthcare providers from adopting these clinically effective therapies. The urgency for advanced wound care solutions is highlighted by the immense burden of chronic diseases; for instance, the 'International Diabetes Federation' reported in '2025' that 'approximately 589 million adults globally are living with diabetes, a primary cause of chronic foot ulcers requiring advanced wound management', illustrating the vast scale of the patient population necessitating these interventions.

Market Driver

The increasing prevalence of chronic and hard-to-heal wounds acts as the primary catalyst for the Global Wound Electrical Stimulation Devices Market. As lifestyle-associated conditions like diabetes and venous insufficiency become more common, there is a surge in complex ulcers requiring treatments that accelerate tissue repair beyond standard care capabilities. This burden is especially pronounced in developed nations, where demographic shifts are increasing the number of patients vulnerable to non-healing lesions. To illustrate this demand, Bonvadis noted in their May 2025 'Global Status and Challenges of Diabetic Foot Ulcers' report that roughly 1.6 million individuals in the United States develop a diabetic foot ulcer annually, presenting a significant opportunity for stimulation technologies designed to reactivate healing in stalled wounds.

Concurrently, the push for cost-effective wound care strategies to minimize hospital duration is fueling the adoption of electrical stimulation devices. Healthcare systems are prioritizing treatment modalities suitable for home care or outpatient settings to alleviate the heavy financial strain linked to prolonged hospitalizations and readmissions for chronic wounds. This economic pressure encourages the integration of portable and wearable units that offer clinical efficacy at a reduced total cost. According to a December 2025 article in 'Fierce Biotech' titled 'A Defining Moment for Wound Care', the U.S. spends nearly $25 billion annually on chronic wound treatment, prompting payers to seek efficient advanced therapies. Evidence of this market momentum is seen in Smith+Nephew's 2025 report, which cited a 12.2% underlying revenue increase in their Advanced Wound Management division during the fourth quarter of 2024.

Market Challenge

A major obstacle impeding the global market's expansion is the substantial acquisition cost of advanced stimulation units combined with inconsistent reimbursement policies. In cost-sensitive regions, healthcare providers are often reluctant to invest in these specialized instruments due to fragmented and unpredictable insurance coverage. When claims are denied or reimbursement rates are inadequate, hospitals and clinics are financially compelled to favor traditional, lower-cost wound care consumables over electrical stimulation devices, even if the latter offer superior healing potential. This economic constraint restricts the technology's adoption rate, effectively capping revenue potential and discouraging broad commercial integration.

Underscoring the severity of the economic strain influencing these restrictive fiscal policies, the 'International Diabetes Federation' stated in '2024' that 'diabetes was responsible for an estimated USD 1.015 trillion in global health expenditure, a massive financial burden that forces health systems to implement strict cost-containment measures'. This overwhelming cost load leads private and public payers to rigorously scrutinize expenses, often resulting in the exclusion of higher-priced adjunctive therapies from standard coverage plans. Consequently, manufacturers face persistent challenges in establishing these devices as standard care options in markets that value immediate budget preservation over long-term therapeutic investment.

Market Trends

The market is being transformed by a shift toward personalized closed-loop therapeutic systems, which allow devices to autonomously adjust stimulation parameters based on real-time feedback. Unlike traditional units that deliver fixed currents, these bioelectronic platforms employ artificial intelligence to analyze healing stages and modulate electrical output accordingly. This functionality improves therapeutic efficiency by customizing treatment to the specific needs of the tissue. Supporting this innovation, a September 2025 article in 'ScienceDaily' titled 'AI-powered smart bandage heals wounds 25% faster' reported that the closed-loop 'a-Heal' device accelerated healing by approximately 25% compared to standard care in preclinical models.

Additionally, the integration of dressings equipped with smart sensors is meeting the demand for continuous, non-invasive monitoring of the wound microenvironment. These advanced dressings contain electrochemical sensors that detect biomarkers such as pH and temperature, serving as early indicators of infection. By providing objective data, these systems enable clinicians to intervene proactively. Illustrating the diagnostic potential of this technology, a July 2025 article in 'Drug Discovery News' titled 'New smart bandage detects real-time biomarkers in chronic wounds' noted that a study involving human participants found a machine learning algorithm could predict wound healing duration with up to 94% accuracy based on sensor data analysis.

Key Market Players

• Accel-Heal Technologies Limited
• Vomaris Innovations, Inc.
• WoundEL Health Care
• Diapulse Corporation
• Sky Medical Technology Ltd.
• Cardinal Health, Inc.
• Talley Group Limited
• Convatec Limited
• DeRoyal Industries, Inc.
• Devon Medical, Inc

Report Scope

In this report, the Global Wound Electrical Stimulation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wound Electrical Stimulation Devices Market, By Product

• Devices with Electrode Pads
• Devices without Electrode Pads

Wound Electrical Stimulation Devices Market, By Indication

• Stage III and IV Pressure Ulcers
• Venous Stasis Ulcers
• Arterial Ulcers
• Diabetic Ulcers
• Others

Wound Electrical Stimulation Devices Market, By End User

• Hospitals
• Specialty Therapy Clinics
• Others

Wound Electrical Stimulation Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Wound Electrical Stimulation Devices Market.

Available Customizations:

Global Wound Electrical Stimulation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wound Electrical Stimulation Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Devices with Electrode Pads, Devices without Electrode Pads)
  • 5.2.2. By Indication (Stage III and IV Pressure Ulcers, Venous Stasis Ulcers, Arterial Ulcers, Diabetic Ulcers, Others)
  • 5.2.3. By End User (Hospitals, Specialty Therapy Clinics, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Wound Electrical Stimulation Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Wound Electrical Stimulation Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Wound Electrical Stimulation Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Wound Electrical Stimulation Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By End User

7. Europe Wound Electrical Stimulation Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Wound Electrical Stimulation Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By End User
  • 7.3.2. France Wound Electrical Stimulation Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Wound Electrical Stimulation Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Wound Electrical Stimulation Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Wound Electrical Stimulation Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By End User

8. Asia Pacific Wound Electrical Stimulation Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Wound Electrical Stimulation Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By End User
  • 8.3.2. India Wound Electrical Stimulation Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Wound Electrical Stimulation Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Wound Electrical Stimulation Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Wound Electrical Stimulation Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By End User

9. Middle East & Africa Wound Electrical Stimulation Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Wound Electrical Stimulation Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Wound Electrical Stimulation Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Wound Electrical Stimulation Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By End User

10. South America Wound Electrical Stimulation Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Wound Electrical Stimulation Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Wound Electrical Stimulation Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Wound Electrical Stimulation Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Wound Electrical Stimulation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Accel-Heal Technologies Limited
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Vomaris Innovations, Inc.
• 15.3. WoundEL Health Care
• 15.4. Diapulse Corporation
• 15.5. Sky Medical Technology Ltd.
• 15.6. Cardinal Health, Inc.
• 15.7. Talley Group Limited
• 15.8. Convatec Limited
• 15.9. DeRoyal Industries, Inc.
• 15.10. Devon Medical, Inc

16. Strategic Recommendations

17. About Us & Disclaimer